Eli Lilly's newly FDA-approved Alzheimer's remedy, established in trials, is believed to barely reduce reminiscence and cognitive lower in sufferers with the sickness, the corporate declared on Tuesday.
Authentic Supply: https://www.parentherald.com/articles/113122/20240703/fda-approves-eli-lillys-drug-kisunla-alzheimer-treatment.htm
Written by: Jackelyn Cornejo on 2024-07-04 03:32:58